INTRODUCTION
In humans, vitamin D is obtained primarily through exposure to ultraviolet B radiation from sunlight and secondarily through a diet including vitamin D-rich foods or supplements. 1 A sunny climate does not ensure immunity to vitamin D deficiency. For example, a recent Australian population-based health survey estimated prevalence of vitamin D deficiency (serum 25-hydroxyvitamin D (25(OH)D)o 50 nmol l − 1 ) amongst adults to be 23%. 2 This is within the range of deficiency prevalence found in other national population-based studies carried out in the United States, Canada, United Kingdom and New Zealand where estimates of deficiency ranged from 18 to 36%. 3 Detrimental effects of prolonged vitamin D deficiency on musculoskeletal health include development of rickets in children and osteomalacia in adults. 4, 5 Associations have also been found between 25 (OH)D levels and many other diseases 6 including cancer, cardiovascular disease, influenza type A, rheumatoid arthritis, and both type 1 and type 2 diabetes mellitus.
Previous twin and family-based studies provide evidence that 25(OH)D levels are determined by a significant genetic component, with estimates of heritability varying widely from 23 to 80%. 7 A number of genome-wide association studies (GWASs) have identified genetic variants associated with 25(OH)D levels, [8] [9] [10] [11] with only one of these focussing on children. 10 This study presents results from a GWAS utilising data from The Western Australian Pregnancy Cohort (Raine) Study 12 (hereinafter referred to as the Raine Study) for 25(OH)D levels measured in blood collected at both the age 6 years and age 14 years follow-ups. Replication of significantly associated genetic variants with 25(OH)D levels from previously published GWASs was also assessed.
RESULTS AND DISCUSSION
Descriptive statistics of the study participants are shown in Table 1 . Differences were seen between estimated 25(OH)D levels for the 12 serum samples measured with both enzyme immunoassay (EIA) and isotope-dilution liquid chromatographytandem mass spectrometry at the age 6 years follow-up (Supplementary Figure S1A) but good agreement is seen between the two assays at the age 14 years follow-up (Supplementary Figure S1B) . In light of this, a larger sample of 50 sera from the age 6 years follow-up were remeasured with liquid chromatography separation coupled tandem mass spectrometry and it can be seen that the EIA appears to overestimate 25(OH)D levels at higher concentrations (Supplementary Figure S1C) , which was also found to be the case in a previous study of 100 serum samples. 13 The main results presented here for both the age 6 years and age 14 years follow-ups are for the GWAS performed on standardised 25 (OH)D levels (described in Methods; standardisation equations shown in Supplementary Figure S2) with results for the GWAS performed on 25(OH)D levels determined by EIA presented in the supplementary information.
Manhattan plots of the GWAS analyses are shown in Figure 1 and Supplementary Figure S3 . Quantile-quantile plots of the observed versus expected − log 10 P-values did not reveal evidence for systematic bias in either the age 6 year follow-up (inflation factor λ = 1.01; Supplementary Figure S4A ) or age 14 year follow-up (inflation factor λ = 1.01; Supplementary Figure S4B ) results. Supplementary Tables S1 and S2 list the top 50 associated single nucleotide polymorphisms (SNPs) for the age 6 years follow-up and the age 14 years follow-up, respectively. Table 2 summarises results for the top SNP in each of the genes of functional interest identified by these top 50 SNPs. Regional plots of association are shown in Figure 2 for both the age 6 years follow-up and the age 14 years follow-up.
Genome-wide significant associations were found for SNPs located within intronic regions of the group-specific component (vitamin D binding protein) (GC) gene on chromosome 4q13 for both the age 6 years (lowest P = 4.2 × 10 − 9 , rs17467825, Figure 2a ) and the age 14 years follow-ups (lowest P = 3.9 × 10 − 9 , rs1155563, Figure 2c ). The GC gene encodes a vitamin D binding protein that transports vitamin D to various tissues of the body.
14 Significant associations were also found for SNPs located on chromosome 11p15 within either the phosphodiesterase 3B, cGMP-inhibited (PDE3B) or cytochrome P450, family 2, subfamily R, polypeptide 1 (CYP2R1) genes for both the age 6 years (lowest P = 3.9 × 10 − 8 , rs1007392, Figure 2b ) and the age 14 years follow-ups (lowest P = 2.2 × 10 − 10 , rs11023332, Figure 2d ). The top associated SNPs on chromosome 11p15 are located in an intron of PDE3B but the true functional association is believed to be with CYP2R1 as these SNPs are in strong linkage disequilibrium with the top associated SNPs in CYP2R1 (Figure 2b and d) . The CYP2R1 gene encodes an enzyme that converts vitamin D to 25(OH)D. 15 Nevertheless, it is also plausible that the association could be with PDE3B because there is evidence that vitamin D and phosphodiesterase 3B are both involved in a common pathway controlling lipid metabolism. 16, 17 Specifically, it is thought that parathyroid hormone promotes conversion of 25(OH)D to 1α,25-dihydroxyvitamin D 3 (1,25(OH) 2 D) which then stimulates calcium influx in adipocytes. This influx of calcium inhibits lipolysis through activation of phosphodiesterase 3B, which suppresses the lipolytic response to catecholamines. 18 Significant associations between 25(OH)D levels and SNPs in GC, CYP2R1, NAD synthetase 1 (NADSYN1) and 7-dehydrocholesterol reductase (DHCR7) have been reported in previous GWASs. [8] [9] [10] [11] We hereafter report the results from our two follow-up analyses for the top reported SNPs in these previous GWASs. Associations with the GC intronic SNP, rs2282679, located on chromosome 4q13 were previously found in the GWASs conducted by Ahn et al. 8 (P = 1.8 × 10 − 49 ), Wang et al. 11 (P = 1.9 × 10 − 109 ) and A flanking distance of 100 kilobases either side of the SNP location was used to define neighbouring genes of functional interest. Genes of functional interest are those genes that are functionally relevant and/or have been found to be associated with vitamin D levels in previous GWASs. Significant associations have been found at the NADSYN1/DHCR7 locus in previous GWASs but SNPs at this locus were not present in our top 50 SNPs (age 6 years follow-up top SNP rs12793607 (P-value 0.0001); age 14 years follow-up top SNP rs4945008 (P-value 0.0002)).
f Only those SNPs residing within the boundary of a gene have a functional class. Figure 2 . Regional LocusZoom association plots for SNPs at GC (age 6 years follow-up (a); age 14 years follow up (c)) and CYP2R1 (age 6 years follow-up (b); age 14 years follow-up (d)). The left-hand y axis shows − log 10 P-values of association. Genotyped SNPs are shown as circles and imputed SNPs are shown as triangles. The top associated SNP is shown in purple. Colour coding of the other plotted SNPs in the region represents linkage disequilibrium (r 2 ) with the top associated SNP that was calculated using 1000 Genomes EUR samples. The recombination rate for the 1000 Genomes EUR samples is indicated by the blue line and the right-hand y axis. The x axis shows the chromosomal position of the SNPs and genes based on NCBI Human Genome Build 37 coordinates.
Lasky-Su et al. 10 (P = 2.1 × 10 − 14 ) and we found a genome-wide significant association for this SNP in our study for the age 6 years follow-up (P = 4.7 × 10
) and a borderline genome-wide significant association for the age 14 years follow-up (P = 5.7 × 10 − 8 ). Ahn et al. 8 reported intronic rs1993116 to be the top associated SNP in the CYP2R1 gene located on chromosome 11p15 (P = 2.9 × 10 − 17 ) and we found suggestive association for this SNP in our study (age 6 years follow-up P = 2.5 × 10 − 6 ; age 14 years follow-up P = 3.6 × 10 − 7 ). Wang et al. 11 found rs10741657 to be the top associated SNP on chromosome 11p15 which is located near CYP2R1 (P = 3.3 × 10 − 20
) and we also found suggestive association for this SNP (age 6 years follow-up P = 2.6 × 10 − 6 ; age 14 years follow-up P = 4.5 × 10 − 7 ). We did not replicate findings of significant associations for SNPs on chromosome 11q13 in the region of NADSYN1 and DHCR7 as reported by both Ahn et al. 8 and Wang et al. 11 The GWASs by Ahn et al. 8 and Wang et al. 11 were large meta-analyses performed on cohorts of European ancestry so the most likely reason for non-replication at NADSYN1 and DHCR7 in our GWAS is lack of power due to the smaller sample sizes used in our study.
When the GWAS was performed on 25(OH)D levels determined by EIA for the age 6 years follow-up, the only genome-wide significant association was for SNPs located on chromosome 7p15, with the top associated SNP, rs156299 (P = 3.0 × 10 − 8 ), being located ≈ 99 kilobases upstream of the neuropeptide Y (NPY) gene (Supplementary Figure S3) . The strength of this association diminished when the GWAS was performed on standardised 25 (OH)D levels ( Figure 1 ) but remains suggestive (P = 1.3 × 10 − 6 , rs156299, Supplementary Figure S5 ). This association was not replicated in our age 14 years follow-up analysis and we are unaware of any previous studies reporting such a finding. One possibility is that this association could be a spurious result in light of the disagreement seen between the EIA and LC-MS assays ( Supplementary Figures S1A and S1C) . It is not surprising to find disagreement between the two assays as it is commonly acknowledged that there is considerable interassay variability when measuring 25(OH)D and it remains unclear which is the 'best' assay. 19 We have presented the GWAS performed on standardised 25(OH)D levels in the main results rather than the GWAS performed on 25(OH)D levels measured by EIA as associations were strengthened for genes found in previous GWASs; from borderline for GC and suggestive for PDE3B/CYP2R1 to genome-wide significant for both genes after standardisation. Notwithstanding this, we considered reasons for a possible association between NPY and 25(OH)D levels. One explanation is that the association between NPY and 25(OH)D levels seen for our age 6 years follow-up analysis relates to differences in the way vitamin D is metabolised in younger children compared to postpubescent children and adults.
NPY is a neurotransmitter found in abundance in the central and peripheral nervous systems. 20 The effects of NPY are mediated by NPY receptors with the subtypes Y1, Y2 and Y5 being the best understood of the receptors. 21 The diverse range of physiological processes mediated by these receptors includes amongst others food intake, bone homeostasis, cardiovascular regulation, mood and circadian rhythm. 22 We consider food intake or bone homeostasis to be the most likely processes underlying the association seen between NPY and 25(OH)D levels in our age 6 years follow-up analysis because vitamin D levels can be altered through food intake and vitamin D plays a vital role in bone homeostasis.
Food intake could be an effect mediator of the association seen between NPY and 25(OH)D levels. This makes the assumption that increasing food intake is associated with ingestion of greater amounts of dietary vitamin D. We did adjust for body mass index in our analyses, but this is not a perfect proxy for food intake and information regarding food intake or vitamin D supplementation was not available. However, if this is the sole reason for the association, it seems likely that we should have seen replication of the association in the age 14 years follow-up analysis.
Animal models have shown that NPY suppresses bone formation through the Y2 receptor in the hypothalamus and locally in the bone through the osteoblastic Y1 receptor. 21 Given that vitamin D is well known to be involved in bone homeostasis, the association seen between NPY and 25(OH)D levels could be through the effect of NPY on bone homeostasis. The active form of vitamin D, 1,25(OH) 2 D, stimulates absorption of calcium from the gastrointestinal tract and reabsorption of calcium from the kidneys into the circulation which is used by osteoblasts to form bone. If NPY suppresses bone formation, then there would presumably be less demand from osteoblasts for circulating calcium, which could lead to suppression of 1,25(OH) 2 D. The fact that the association was only seen for the age 6 years follow-up analysis and not the age 14 years follow-up analysis could be because of a difference in the primary bone homeostasis pathways at age 6 versus age 14. In particular, sex hormones are major contributors to bone homeostasis from commencement of puberty, 23 which is relevant for our age 14 years follow-up data but not our age 6 years follow-up data. Pertaining to this, 88% of the 14-year-old females had experienced menarche prior to blood collection. Interestingly, studies using animal models have found that NPY and sex hormones interact in the bone homeostasis pathway 24 further highlighting the difference expected in bone homeostasis at age 6 versus age 14.
In conclusion, we have conducted a GWAS of serum 25(OH)D levels in children at ages 6 and 14 years. We have replicated findings found in previous GWASs and present a possible novel finding for the age 6 years follow-up analysis. Replication of this novel finding in another cohort of the same age is recommended.
MATERIALS AND METHODS
The Raine Study obtained consent from study participants and ethics approval for recruitment and subsequent follow-ups from the Ethics Committee at King Edward Memorial Hospital and/or Princess Margaret Hospital (Perth, WA, Australia). Measurement of 25(OH)D levels in the age 6 years and age 14 years follow-ups has been described previously. 25 Collection of serum samples took place over a 3-year period; from 1995 to 1998 for the age 6 years follow-up and from 2003 to 2006 for the age 14 years follow-up. Serum from the age 6 years (n = 989) and age 14 years (n = 1 380) follow-ups stored at − 80°C was thawed and 25(OH)D levels were measured using the Immunodiagnostic Systems Inc. 25(OH)D EIA kit (Scottsdale, AZ, USA). Inter-plate coefficients of variation (CV) were determined using control samples for both the age 6 years follow-up (CV = 6.5% at mean 25(OH)D of 32 nmol l . Measurement of 25(OH)D was also repeated for 12 samples at both the age 6 years and age 14 years follow-ups using isotope-dilution liquid chromatography-tandem mass spectrometry 26 performed by RMIT Drug Discovery Technologies (Melbourne, VIC, Australia) and for 50 samples at the age 6 years follow-up using two-dimensional ultra performance liquid chromatography separation coupled tandem mass spectrometry 27 performed by Metabolomics Australia (Crawley, WA, Australia).
Genomic DNA was extracted from whole blood or saliva (≈ 5% of samples) collected at the age 14 or 17 years follow-ups. Genotyping of the samples (n = 1 593) was performed by the Centre for Applied Genomics (Toronto, ON, Canada) using the Illumina Human660W-Quad BeadChip (Illumina Inc., San Diego, CA, USA). The SNP genotyping data were subjected to a number of quality control checks within PLINK. 28 Samples where more than 3% of SNP genotypes were called as missing were excluded (n = 16) and this removed all samples with excessive heterozygosity rates. Samples with an excessive homozygosity rate were also excluded (n = 3; Fixation index 40.07). Exclusions were made because of gender discrepancies between reported gender and gender inferred from the X chromosome data (n = 7). Where pairs of samples showed relatedness equivalent to second-degree relatives or greater (estimated Novel pathways for vitamin D metabolism in children D Anderson et al identity by descent 40.1875), the member of the pair with the highest missing SNP genotyping call rate was removed (n = 73). Of the 1494 samples passing quality control, 25(OH)D measurements were available for 673 participants at the age 6 year follow-up and 1140 participants at the age 14 year follow-up.
Quality control of the SNPs included exclusions based on a call rate less than 95%, evidence of deviation from Hardy-Weinberg equilibrium (Po5.7 × 10 − 7 ) and minor allele frequency less than 1%. Imputation of untyped SNPs was performed using MaCH 29 with the HapMap Phase II (Release 22) CEU samples as reference genotypes for prediction. Imputed SNPs with a minor allele frequency less than 1% or a MaCH r 2 quality score less than 0.3 were excluded. This increased the number of SNPs available for analysis from the 535 632 passing quality control to 2 461 244.
Standardisation of 25(OH)D levels for the age 6 year and age 14 year follow-ups was performed by fitting a weighted Deming regression model in R 30 using the mcreg() function available in the mcr package. 31 The two models were fitted using the 50 age 6 year samples remeasured with liquid chromatography separation coupled tandem mass spectrometry and the 12 age 14 year samples remeasured with isotope-dilution liquid chromatography-tandem mass spectrometry. These models were used to predict 25(OH)D levels as measured by liquid chromatography separation coupled tandem mass spectrometry at age 6 and by isotope-dilution liquid chromatography-tandem mass spectrometry at age 14 for the remainder of each cohort based on 25(OH)D levels measured by EIA.
Given that the serum samples were collected throughout all seasons of the year, a cosinor model was used to remove the seasonal variability in 25 (OH)D levels. The cosinor model was fitted in R using the cosinor() function available in the season package. 32 Deseasonalisation of 25(OH)D levels was performed by adding the overall mean 25(OH)D level to each individual's actual 25(OH)D level minus their predicted 25(OH)D level. 33 Imputed SNP allele dosages were tested for association with logtransformed, deseasonalised 25(OH)D levels under an additive linear regression model using ProbABEL v.0.3.0. 34 Models were adjusted for gender and body mass index. To adjust for population stratification, principal component analysis was carried out on a set of 42 888 pruned SNPs in linkage equilibrium (pairwise r 2 ⩽ 0.1) using the smartpca program (available in the EIGENSTRAT 35 suite of programs) and ancestry estimates from the top five principal components were included in the models.
Manhattan plots of the GWAS results were generated in R using the manhattanplot() function available in the postgwas package. 36 Genome-wide significant associations were defined as (P ⩽ 5 × 10 ). 37 Regional plots of association were generated using LocusZoom. 38 The SNP functional class and neighbouring genes were obtained from NCBI using the GetSNPInfo() and GetNeighGenes() functions available in the NCBI2R package. 39 
